<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP07776571A1" file="07776571.7" lang="en" country="EP" doc-number="2089521" kind="A1" date-publ="20090819" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..MT......</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  1100000/0</B007EP></eptags></B000><B100><B110>2089521</B110><B130>A1</B130><B140><date>20090819</date></B140><B190>EP</B190></B100><B200><B210>07776571.7</B210><B220><date>20070501</date></B220><B240><B241><date>20090520</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>862350 P</B310><B320><date>20061020</date></B320><B330><ctry>US</ctry></B330><B310>PCT/US2006/000436</B310><B320><date>20061110</date></B320><B330><ctry>WO</ctry></B330></B300><B400><B405><date>20090819</date><bnum>200934</bnum></B405><B430><date>20090819</date><bnum>200934</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12N  15/12        20060101AFI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07K  14/715       20060101ALI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C12N  15/11        20060101ALI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  38/17        20060101ALI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K  48/00        20060101ALI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>C07H  21/00        20060101ALI20080516BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>A61P  29/00        20060101ALI20080516BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>LÖSLICHE TNF-REZEPTOREN UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON KRANKHEITEN</B542><B541>en</B541><B542>SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE</B542><B541>fr</B541><B542>RÉCEPTEURS DE TNF SOLUBLES ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES</B542></B540></B500><B700><B710><B711><snm>Ercole Biotech, Inc.</snm><iid>08010570</iid><irf>22460-0016EP1</irf><adr><str>79 TW Alexander Dr.</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B711><B711><snm>The University of North Carolina At Chapel Hill</snm><iid>08081030</iid><irf>22460-0016EP1</irf><adr><city>Chapel Hill NC 27599-4105</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>SAZANI, Peter L.</snm><adr><str>5 Tupelo Lane</str><city>Chapel Hill, NC 27514</city><ctry>US</ctry></adr></B721><B721><snm>GRAZIEWICZ, Maria</snm><adr><str>1131 Arborgate Circle</str><city>Chapel Hill, NC 27514</city><ctry>US</ctry></adr></B721><B721><snm>KOLE, Ryszard</snm><adr><str>203 Longwood Drive</str><city>Chapel Hill, NC 27514</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Peterreins, Frank</snm><iid>09286021</iid><adr><str>Fish &amp; Richardson P.C. 
Highlight BusinessTowers 
Mies-van-der-Rohe-Strasse 8</str><city>80807 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2007010556</anum></dnum><date>20070501</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2008051306</pnum></dnum><date>20080502</date><bnum>200818</bnum></B871></B870></B800></SDOBI></ep-patent-document>